Rodney Dausch

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA.

Fletcher Spaght, Inc. provides strategy consulting and market research services. It offers finance assistance to new ventures in the fields of health care and high technology. The firm also has a venture capital firm that accepts equity interest in a client in place of consulting fees. The company was founded in 1983 by John Fletcher and is headquartered in Boston, MA.

Healthvision Solutions, Inc. develops software products. The company's software and service offerings include an integrated suite of application development tools and vertical enterprise applications for companies in healthcare, financial services, software, telecommunications, public sector, manufacturing and life sciences. The company was founded in 1989 and is headquartered in Irving, TX.

3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases

BioTrove, Inc. develops, manufactures and markets systems, consisting of laboratory instruments and related consumables, for genomic analysis, high-throughput screening and molecular diagnostics. The company was founded by Tanya S. Kanigan and Colin J. H. Brenan in 2000 and is headquartered in Woburn, MA.

GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ.

MedVentive, Inc. provides healthcare and medical technology solutions for healthcare delivery networks, payers and employer coalitions. It offers medical cost containment and healthcare quality improvement solutions. MedVentive architects its solutions to deliver sophisticated data management systems and resources to leading provider organizations. The firm combining clinical data from multiple sources, MedVentive calculates clinical measures accurately, manages patient interventions efficiently, and impacts your bottom line directly. The company was founded by Jonathan M. Niloff in 1997 and is headquartered in Waltham, MA.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

IlluminOss Medical, Inc. engages in the designing, developing, and marketing of orthopedic fracture repair products. The company was founded by Robert A. Rabiner and Arnold-Peter C. Weiss in 2007 and is headquartered in East Providence, RI.

Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA.

ShapeUp, Inc. provides social networking and incentives-based employee wellness programs. It offers Social Wellness, a platform that uses social networking, gaming, behavioral economics, and financial rewards to support employers and health plans. The firm’s solution features health challenges, progress tracing, incentives, integration, and reporting. It also provides an online tracking interface that allows participants to customize the categories to track, including exercise minutes, pushups per day, and number of hours slept. The firm also offers Empower, an online weight loss and diabetes prevention solution. The company was founded by Rajiv Kumar and Brad Weinberg in 2006 and is headquartered in Providence, RI.

GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium.

New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY.

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

The Gi Company Inc. develops drugs to treat gastrointestinal and related diseases. It offers intestinal trefoil factor for the treatment of oral mucositis. The company also has projects in enteritis, proctitis, inflammatory bowel disease, erosive gastro esophageal reflux disease, peptic ulcer disease and gastrointestinal motility disorders, as well as clinical programs in erosive gastritis, ulcerative colitis and corneal wound healing. The company was founded in 1998 and is headquartered in Framingham, MA.

Hsiri Therapeutics LLC engages in the discovering and developing therapies for infections due to drug resistant bacteria. Its research efforts are focuses on two major areas including infections due to mycobacteria and infections due to usual bacterial pathogens. The firm also developing compounds aimed at traditional bacterial infections caused by drug resistant bacteria. The company was founded by Dennis F. Willson and is headquartered in Media, PA.

Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno.

Zeronorth, Inc. develops and operates continuous application security platform. The CYBRIC platform integrates security into the development process and delivers frictionless security assurance from code commit to application delivery. The company was founded by Ernesto DiGiambattista, Andrew Gilman, Mike Kail, and Sean B. Walter in 2015 and is headquartered in Boston, MA.

NP-C Therapeutics LLC develops pharmaceutical products for treatment of Niemann-Pick Type C disease. The company was incorporated in 2014 and is headquartered in King of Prussia, PA.

Petrillo Capital (Petrillo Capital) is a venture capital firm founded in 2015 by Enrico Petrillo. The firm is headquartered in Boston, Massachusetts.

Navrogen, Inc. is a biotechnology company, which engages in the discovery and development of tumor produced HIO-factors that are associated with cancer prognosis and therapeutic response of immune-mediated anti-cancer therapies. The company was founded by Luigi Grasso and Nicholas C. Nicolaides in 2017 and is headquartered in Philadelphia, PA.

Ranedis Pharmaceuticals operates as a biopharmaceutical company. The company was founded by William Claypool and Denny Willson and is headquartered in Media, PA.